AIM
RKDA icon

Axiom Investment Management’s Arcadia Biosciences RKDA Stock Holding History

Axiom Investment Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38
Closed -$1K – 352
2022
Q3 		$1K Buy
+38
New +$1.3K ﹤0.01% 387

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Axiom Investment Management's RKDA Position: Q4 2022 in Review

Axiom Investment Management sold out of Arcadia Biosciences (RKDA) in Q4 2022, closing a stake of 38 shares — an estimated $1K sold.

Axiom Investment Management first reported a position in RKDA in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 28 funds tracked by Wall St. Rank hold RKDA as of Q4 2022.

  • Axiom Investment Management reported no remaining Arcadia Biosciences position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 38 Arcadia Biosciences shares in Q4 2022, an estimated $1K.
  • Axiom Investment Management first reported a position in Arcadia Biosciences in Q3 2022 and held it in 1 quarter.
  • Axiom Investment Management's Arcadia Biosciences position peaked at $1K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.